Issued Patents 2018
Showing 1–25 of 25 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10160801 | Nucleic acids encoding chimeric and humanized anti-histone antibodies | Chien-Hsing Chang, Hans J. Hansen | 2018-12-25 |
| 10143756 | Antibody-SN-38 immunoconjugates with a CL2A linker | Serengulam V. Govindan, Jonathan B. Gale, Nicholas J. Holman | 2018-12-04 |
| 10137196 | Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity | Serengulam V. Govindan | 2018-11-27 |
| 10130626 | Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity | Serengulam V. Govindan | 2018-11-20 |
| 10131712 | Combination therapy with T-cell redirecting bispecific antibodies and checkpoint inhibitors | Edmund A. Rossi, Chien-Hsing Chang | 2018-11-20 |
| 10130718 | Antibody-drug conjugates and uses thereof | Serengulam V. Govindan | 2018-11-20 |
| 10111954 | Combination therapy for inducing immune response to disease | Chien-Hsing Chang, Edmund A. Rossi, Diane Rossi, Hans J. Hansen | 2018-10-30 |
| 10064957 | Immunoconjugates with an intracellularly-cleavable linkage | Serengulam V. Govindan, Sung-Ju Moon | 2018-09-04 |
| 10058621 | Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic cancers | Thomas M. Cardillo | 2018-08-28 |
| 10040848 | Chimeric and humanized anti-histone antibodies | Chien-Hsing Chang, Hans J. Hansen | 2018-08-07 |
| 10034950 | Antibody-SN-38 immunoconjugates with a CL2A linker | Serengulam V. Govindan, Jonathan B. Gale, Nicholas J. Holman | 2018-07-31 |
| 10022427 | Interferon lambda-antibody complexes | Chien-Hsing Chang, Donglin Liu | 2018-07-17 |
| 9999668 | RS7 antibodies | Serengulam V. Govindan, Zhengxing Qu, Hans J. Hansen | 2018-06-19 |
| 9993547 | T20 constructs for anti-HIV (human immunodeficiency virus) therapy and/or vaccines | Sofia Stenler, Britta Wahren, Chien-Hsing Chang | 2018-06-12 |
| 9963516 | Stable compositions of high-concentration allotype-selected antibodies for small-volume administration | Li Zeng, Rohini Mitra, Edmund A. Rossi, Hans J. Hansen | 2018-05-08 |
| 9963507 | Therapeutic use of anti-CD22 antibodies for inducing trogocytosis | Chien-Hsing Chang, Hans J. Hansen, Edmund A. Rossi | 2018-05-08 |
| 9944703 | Humanized anti-CD22 antibody | Chien-Hsing Chang | 2018-04-17 |
| 9931413 | Tetrameric cytokines with improved biological activity | Chien-Hsing Chang, Edmund A. Rossi | 2018-04-03 |
| 9932413 | Murine, chimeric, humanized or human anti-IL-6 antibodies | Rongxiu Li, Chien-Hsing Chang | 2018-04-03 |
| 9931417 | Antibody-SN-38 immunoconjugates with a CL2A linker | Serengulam V. Govindan, Jonathan B. Gale, Nicholas J. Holman | 2018-04-03 |
| 9920116 | Methods for treating ischemic stroke using chimeric and humanized anti-histone antibodies | Chien-Hsing Chang, Hans J. Hansen | 2018-03-20 |
| 9879088 | Disease therapy by inducing immune response to Trop-2 expressing cells | Chien-Hsing Chang, Edmund A. Rossi, Diane Rossi | 2018-01-30 |
| 9872920 | PEGylation by the dock and lock (DNL) technique | Chien-Hsing Chang, William J. McBride, Edmund A. Rossi | 2018-01-23 |
| 9862770 | Multivalent antibody complexes targeting IGF-1R show potent toxicity against solid tumors | Chien-Hsing Chang | 2018-01-09 |
| 9855344 | Antibody-SN-38 immunoconjugates with a CL2A linker | Serengulam V. Govindan, Jonathan B. Gale, Nicholas J. Holman | 2018-01-02 |